⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL784740 | 0.82 | — | — | |
| SCHEMBL23618012 | 0.78 | — | — | |
| SCHEMBL19564875 | 0.76 | — | — | |
| SCHEMBL14027601 | 0.76 | — | — | |
| SCHEMBL15371562 | 0.76 | KMT2A (0.32) | — | |
| SCHEMBL12832045 | 0.74 | PARL (0.31) | — | |
| SCHEMBL18875534 | 0.74 | PARL (0.31) | — | |
| SCHEMBL12482068 | 0.74 | GLA (0.36) | — | |
| SCHEMBL17861182 | 0.73 | — | — | |
| SCHEMBL13495310 | 0.72 | BRD4 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11837750-B2 | Lithium ion battery using crosslinkable separator | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-12-05 | — | — | US | disclosed |
| US-20230120715-A1 | Lithium Ion Battery Using Crosslinkable Separator | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-20 | — | — | US | disclosed |
| US-20180042996-A1 | Hydrogel-Linked IL-1ra Prodrug | ASCENDIS PHARMA OSTEOARTHRITIS DIVISION A/S (DK) | 2018-02-15 | — | — | US | disclosed |
| US-9834808-B2 | Methods for rapid antibiotic susceptibility testing | SeLux Diagnostics, Inc. (US) | 2017-12-05 | — | — | US | disclosed |
| US-9764040-B2 | Spliceostatin analogs and methods for their preparation | PFIZER INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170211121-A1 | Methods for Rapid Antibiotic Susceptibility Testing | OXFORD FINANCE LLC | 2017-07-27 | — | — | US | disclosed |
| US-9676811-B2 | Testosterone derivatives with a carboxyalkyl substitution in position 3 and use thereof for the production of labelled steroids for determining the concentration of testosterone in a biological sample | BIOMERIEX (FR) | 2017-06-13 | — | — | US | disclosed |
| US-9062065-B2 | Process for preparation of darunavir and darunavir ethanolate of fine particle size | LUPIN LIMITED (IN) | 2015-06-23 | — | — | US | disclosed |
| US-9062067-B2 | Process for preparation of darunavir and darunavir ethanolate of fine particle size | LUPIN LIMITED (IN) | 2015-06-23 | — | — | US | disclosed |
| US-9044505-B2 | Multimeric biotinidase resistant multimodality probes | MISRA, PREETI | 2015-06-02 | — | — | US | disclosed |
| US-20140066638-A1 | NOVEL PROCESS FOR PREPARATION OF DARUNAVIR AND DARUNAVIR ETHANOLATE OF FINE PARTICLE SIZE | LUPIN LIMITED (IN) | 2014-03-06 | — | — | US | disclosed |
| US-8404678-B2 | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | SANOFI (FR) | 2013-03-26 | — | — | US | disclosed |
| US-20120237770-A1 | NOVEL PROCESS FOR PREPARATION OF DARUNAVIR AND DARUNAVIR ETHANOLATE OF FINE PARTICLE SIZE | LUPIN LIMITED (IN) | 2012-09-20 | — | — | US | disclosed |
| US-20120226019-A1 | COMPOUNDS AND METHODS FOR PURIFYING PEPTIDES PRODUCED BY SOLID PHASE PEPTIDE SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (FR) | 2012-09-06 | — | — | US | disclosed |
| US-20100316656-A1 | CYTOTOXIC AGENTS COMPRISING NEW TOMAYMYCIN DERIVATIVES AND THEIR THERAPEUTIC USE | SANOFI-AVENTIS (FR) | 2010-12-16 | — | — | US | disclosed |